Telix Pharmaceuticals Ltd
F:T3X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
Tokio Marine Holdings Inc
OTC:TKOMF
|
JP |
|
CK Asset Holdings Ltd
F:1CK
|
HK |
|
S
|
Sprouts Farmers Market Inc
F:1FA
|
US |
|
Community West Bancshares
NASDAQ:CWBC
|
US |
|
S
|
Santana Minerals Ltd
OTC:SEQP
|
AU |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
Flight Centre Travel Group Ltd
ASX:FLT
|
AU |
|
A
|
Anika Therapeutics Inc
F:AKP
|
US |
|
Medx Health Corp
XTSX:MDX
|
CA |
|
B
|
Brookfield Business Corp
TSX:BBUC
|
US |
Wall St Price Targets
T3X Price Targets Summary
Telix Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for T3X is 13.936 EUR with a low forecast of 10.47 EUR and a high forecast of 19.35 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is T3X's stock price target?
Price Target
13.936
EUR
According to Wall Street analysts, the average 1-year price target for T3X is 13.936 EUR with a low forecast of 10.47 EUR and a high forecast of 19.35 EUR.
What is the Revenue forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Revenue has been 228%. The projected CAGR for the next 8 years is 12%.
What is the Gross Profit forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
16%
The compound annual growth rate for Gross Profit over the next 8 years is 16%.
What is the Operating Income forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
41%
The compound annual growth rate for Operating Income over the next 8 years is 41%.
